Category: Cardiac Rhythm Management
Acutus Medical secured $26.2 million in new funding for its cardiac mapping technology.
Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it's developing to image and map atrial fibrillation hotspots.
Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.
Boston Scientific loses a $309 million judgment in its long-running patent war with Mirowski Family ventures over cardiac pacemaker technology.
UPDATED Sept. 25, 2014, with comment from Boston Scientific.
CE Mark approval expands the company's portfolio of cardiac rhythm devices with MRI compatibility.
St. Jude Medical lands European approval to market its Tendril STS and IsoFlex Optim leads as safe for MRI scanning, adding that the company's just getting started on a larger MRI-safe campaign.
Medtronic says it won CE Mark approval in the European Union for the Tyrx cardiac device envelope it paid $160 million for earlier this year.
Medtronic makes the final payment in the $11.1 million settlement of allegations that it ran a kickbacks scheme to influence sales of its cardiac rhythm management products, but admits no wrongdoing.